MedTrace Logo

0.01% Hypochlorous Acid in the Treatment of Blepharitis

NCT05608980 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-11-08

No results posted yet for this study

Summary

This is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.

Conditions

  • Blepharitis

Interventions

DRUG

0.01% hypochlorous acid

once daily 0.01% hypochlorous acid topical treatment via ultrasonic atomization for 2 weeks

DRUG

Placebo

once daily eyelid wipes for 2 weeks

Sponsors & Collaborators

  • ShuGuang Hospital

    collaborator OTHER

  • Eye & ENT Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Jiaxu Hong · Eye & ENT Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-12-01
Completion
2023-05-01

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05608980 on ClinicalTrials.gov